NIH spot­lights trio of aca­d­e­m­ic teams chas­ing af­ter 'pan-coro­n­avirus' vac­cines

Hav­ing made loud and clear its call for new re­search on vac­cines that can tack­le fu­ture pan­demics, the NIH is shed­ding light on some of the projects it’s fund­ing.

The Na­tion­al In­sti­tute of Al­ler­gy and In­fec­tious Dis­eases (NI­AID) has award­ed around $36.3 mil­lion to three aca­d­e­m­ic groups that are work­ing on de­vel­op­ing “pan-coro­n­avirus vac­cines” — in­oc­u­la­tions that can pro­tect against a di­verse fam­i­ly of coro­n­avirus­es, es­pe­cial­ly the vo­ra­cious ones like SARS-CoV-2.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER